Skip to main content

IMI projects delivering quality and quantity on publications


The sheer volume and high quality of publications coming out of IMI projects is highlighted in the latest analysis of IMI publications carried out by Clarivate Analytics (formerly Thomson Reuters).

IMI has been monitoring and analysing the papers coming out of its projects since 2012, and the number of publications is increasing year-on–year. In 2016 alone, IMI projects produced 796 publications, bringing the total number of publications produced by IMI projects to over 2 600. With the number of IMI projects on the rise, this trend is set to continue for the coming years.

The field-normalised citation impact for all IMI papers is 2.03 (compared to 1.14 for the EU and the baseline of 1 for the world). This is similar to the result in previous years and shows that IMI is maintaining a high standard even as its output increases.

Other key facts and figures revealed by the latest analysis include the following.

  • 25% of papers from IMI projects are ‘highly cited’, meaning they are in the top 10 % of papers by journal category and year of publication.
  • IMI projects have published in a total of 796 journals, and the average journal impact factor for IMI research is 5.968.
  • Journals with a particularly high impact factor that have published IMI research include: Lancet Neurology, Science Translational Medicine, Nature (and other Nature journals e.g. Nature Genetics, Nature Medicine, and Nature Neuroscience), Science, and the Journal of the American Medical Association (JAMA).
  • The collaborative nature of IMI is reflected in the authorship of the papers, with over half of papers (58.4%) recording authors from more than one country.

A collaborative initiative

The report highlights how IMI project research is collaborative across sectors, institutions and countries. More than half (62.8%) of IMI project papers were published by co-authors affiliated with more than one sector. More than three-quarters (80.7%) of IMI project papers involved collaboration between institutions. And more than half (57.1%) of all IMI project papers were internationally collaborative. The metrics for all types of collaboration have increased since the previous report.

Project snapshot

Going by the number of papers produced, the most prolific projects are unsurprisingly the older ones. The top 10 are:


No. papers

BTCURE (rheumatoid arthritis)


EU-AIMS (autism spectrum disorder)


NEWMEDS (schizophrenia & depression)


EUROPAIN (chronic pain)


IMIDIA (diabetes)


EMIF (knowledge management, diabetes, Alzheimer’s disease)


PROTECT (medicines safety)


SUMMIT (diabetes)


CHEM21 (green chemistry)


eTOX (medicines safety)



Find out more

Download the full report